Paul Singer’s Elliot Management nominates 6 for Actelion’s Board

March 20th, 2011
| More
Elliot Management, Paul Singer’s New York-based hedge fund firm, has nominated six ex-pharmaceutical executives and banking experts to Actelion Ltd’s Board of Directors. According to an article on Reuters, Elliot Management, Actelion’s largest shareholder, has also called on the Swiss biotech firm to consider putting itself up for sale after disappointing product results last year.

Elliot Management proposed that ex-Novartis development head James Shannon take the reins from Robert Cawthorn as Actelion chairman. In addition, Paul Singer’s hedge fund has proposed 5 additional candidates for the Board: Peter Allen, Anders Haerfstrand, Robert Hock, Elmar Schnee, and Hans-Christian Semmler. Elliot Management has also called for founder and CEO Jean-Paul Clozel to resign from his board position but stay on as CEO.
For Detailed Investor Profiles on these Investors, click below:
Elliott Management Corporation
Related People: Brian Miller*; Gordon Singer; Jon Pollock; Paul Singer
Related Entities: Elliott Associates; Elliott International; Elliott Management Corp
Related Article Tags: Shareholder Activists, Corporate Raiders and Proxy Battles

More Recent Headlines

Nelson Peltz’s Trian Fund takes another shot at Family Dollar Stores

Fortress Investment Group launches Asia focused hedge fund

FBI investigation spurs closures of Loch Capital, Level Global & Barai Capital

Corporate Cash Hoarding and The Great Recession

Hedge Fund Job Report: Baupost Group, Granahan, Samlyn Capital, Trian Group, Paulson & Azentus Capital

Top hedge funds lead industry assets to $1.3 Trillion mark

Harbinger Capital-backed LightSquared ponders IPO

Elliot Management nominates 4 candidates for Iron Mountain’s Board

John Paulson opens Hong Kong office

Carl Icahn signs waiver to buy nearly 20% of Dynegy